By Colin Kellaher
Shares of TFF Pharmaceuticals slid more than 30% in premarket trading Tuesday after the clinical-stage biopharmaceutical company said it was raising $5 million in a dilutive public offering.
The Fort Worth, Texas, company said it is selling nearly 19.9 million shares at 25 cents apiece, about 44% below Monday’s closing price…
Read the full article here
